Discussion Of Insulin Dose And Effection In Type 2 Diabetes With CSII And MDI

Objective: To assess the insulin dose and blood glucose fluctuation in Type 2 Diabetes with CSII and MDI.Methods: 223 Type 2 diabetic Patients was treated with CSII to control gulucose level.when their glucose levels reached the target,the mode of treatment switched to MDI. After the MDI treatment when the glucose levels reached the target too, the daily dose of insulin that needed and the level of blood glucose in each period were recorded for comparison.Results: When blood glucose reached the target, the daily insulin dose of MDI is (48.73±17.30)u, there was no statistical difference between CSII(47.90±15.90)u and MDI. Under the MDI treatment, the insulin dose Before Bedtime accounted for 27.98 percent of total quantity. Before breakfast was 25.7%, before lunch was 23.69%, before dinner was 22.63%. The average blood glucose of MDI is (8.20±1.33)mmol/L, there was no statistical difference between CSII(8.36±1.45)mmol/L and MDI too. The incidence of hypoglycaemia under MDI treatment is 23.32%, which was statistical more than that of CSII (14.35%). The blood glucose fluctuation of MDI is greater than CSII.Conclusion: There was no difference in insulin dose and the level of blood glucose between CSII and MDI. But MDI was greater than CSII in the incidence of hypoglycaemia and blood glucose fluctuation. 2. With the MDI treatment, the insulin dose Before Bedtime accounted for 27.98 percent of total quantity. Before Breakfast was 25.70%, before lunch was 23.69%, Before dinner Was 22.63%.